首页> 外文期刊>Journal of Medicinal Chemistry >Structure-activity relationship studies on 1-(2-(4-Phenylphenoxy)ethyl)pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.
【24h】

Structure-activity relationship studies on 1-(2-(4-Phenylphenoxy)ethyl)pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.

机译:结构-活性关系研究1-(2-(4-苯基苯氧基)乙基)吡咯烷(SC-22716),白三烯A(4)(LTA(4))水解酶的有效抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Leukotriene B(4) (LTB(4)) is a pro-inflammatory mediator that has been implicated in the pathogenesis of a number of diseases including inflammatory bowel disease (IBD) and psoriasis. Since the action of LTA(4) hydrolase is the rate-limiting step for LTB(4) production, this enzyme represents an attractive pharmacological target for the suppression of LTB(4) production. From an in-house screening program, SC-22716 (1, 1-[2-(4-phenylphenoxy)ethyl]pyrrolidine) was identified as a potent inhibitor of LTA(4) hydrolase. Structure-activity relationship (SAR) studies around this structural class resulted in the identification of a number of novel, potent inhibitors of LTA(4) hydrolase, several of which demonstrated good oral activity in a mouse ex vivo whole blood assay.
机译:白三烯B(4)(LTB(4))是促炎性介质,已与包括炎症性肠病(IBD)和牛皮癣在内的多种疾病的发病机制有关。由于LTA(4)水解酶的作用是LTB(4)生产的限速步骤,因此该酶代表了抑制LTB(4)生产的诱人药理学目标。通过内部筛选程序,SC-22716(1,1- [2-(4-苯基苯氧基)乙基]吡咯烷)被确定为LTA(4)水解酶的有效抑制剂。围绕此结构类别的结构活性关系(SAR)研究导致鉴定了许多新型的,有效的LTA(4)水解酶抑制剂,其中几种在小鼠离体全血试验中表现出良好的口服活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号